Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

被引：28
|
作者：
de la Rubia, Javier [1 ,2 ]
Roig, Monica [1 ]
Ibanez, Angela [3 ]
Garcia, Inmaculada [5 ]
Vera, Jose A. [4 ]
Aguilar, Carlos [6 ]
del Campo, Raquel [7 ]
Gonzalez, Nicolas [8 ]
Martinez, Rafael [9 ]
Palomera, Luis [10 ]
Picon, Isabel [11 ]
Rodriguez, Juan N. [12 ]
Sanz, Miguel A. [1 ]
机构：
[1] Hosp La Fe, E-46009 Valencia, Spain
[2] Univ Catolica San Vicente Martir, Valencia, Spain
[3] Gen Hosp, Albacete, Spain
[4] Hosp Virgen Macarena, Seville, Spain
[5] Gen Hosp, Castellon de La Plana, Spain
[6] Hosp Santa Barbara, Soria, Spain
[7] Hosp Son Llatzer, Palma de Mallorca, Spain
[8] Hosp Gen Obispo Polanco, Teruel, Spain
[9] Hosp Clin San Carlos, Madrid, Spain
[10] Hosp Lozano Blesa, Zaragoza, Spain
[11] Inst Valenciano Oncol, Valencia, Spain
[12] Hosp Juan Ramon Jimenez, Huelva, Spain
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2010年 / 85卷 / 04期
关键词：
RENAL-FAILURE; PLUS DEXAMETHASONE; THALIDOMIDE; COMBINATION; THERAPY;
D O I：
10.1111/j.1600-0609.2010.01500.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [31] The Efficacy and Safety of Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Real Clinical Practice : A Study of the Korean Multiple Myeloma Working Party (KMMWP)
    Lee, Ho Sup
    Min, Chang Ki
    Kim, Kihyun
    Lee, Je-Jung
    Bang, Soo-Mee
    Kim, Jin Seok
    Eom, Hyeon Seok
    Lee, Jae Hoon
    Yoon, Do Hyun
    Kim, Inho
    Shin, Ho-Jin
    Park, Yong
    Jo, Jae-Cheol
    Lee, Won Sik
    Mun, Yeung-Chul
    Kim, Hyo Jung
    Park, Seong Kyu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E74 - E75
  • [32] Impact of Dialysis Dependence on Survival for Multiple Myeloma Patients with Renal Impairment: A Multicenter Retrospective Study in China
    Jian, Yuan
    Zhou, Huixing
    Xie, Weiwei
    Ren, Yuan
    Zhang, Zhiyao
    Yang, Guangzhong
    Geng, Chuanying
    Jia, Jing
    Chen, Wenming
    Li, Jian
    Huang, Wenrong
    Cen, Xinan
    Gao, Wen
    BLOOD, 2022, 140 : 12635 - 12636
  • [33] Lenalidomide, bortezomib, and dexamethasone in patients with newly diagnosed multiple myeloma (MM): Final results of a multicenter phase I/II study
    Anderson, K. C.
    Weller, E.
    Lonial, S.
    Jakubowiak, A. J.
    Jagannath, S.
    Raje, N. S.
    Avigan, D.
    Knight, R. D.
    Esseltine, D.
    Richardson, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in 295 Japanese patients with relapsed/refractory multiple myeloma
    Iino, Masaki
    Horigome, Yuichi
    Harazaki, Yoriko
    Kobayashi, Takahiro
    Handa, Hiroshi
    Hiramatsu, Yasushi
    Kuroi, Taiga
    Tanimoto, Kazuki
    Matsue, Kosei
    Yoshida, Takahiro
    Mori, Ikuo
    Abe, Masahiro
    Akagi, Kiwamu
    Hayashi, Toshiaki
    Ishida, Tadao
    Ito, Shigeki
    Iwasaki, Hiromi
    Kuroda, Junya
    Maeda, Takahiro
    Shibayama, Hirohiko
    Sunami, Kazutaka
    Takamatsu, Hiroyuki
    Tamura, Hideto
    Shinozaki, Tomohiro
    Iida, Shinsuke
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S172 - S172
  • [35] TREATMENT OF MULTIPLE RELAPSED/REFRACTORY MYELOMA WITH LENALIDOMIDE DEXAMETHASONE RETROSPECTIVE ANALYSIS OF 65 PATIENTS TREATED AT A CENTER
    Moya Arnao, M.
    Cabanas Perianes, V
    Moreno Balmonte, M. J.
    Martinez Marin, A.
    Fernandez Poveda, E.
    Navarro Almenzar, B.
    Berenguer Piqueras, M.
    Salido Fierez, E.
    Labbadia, F.
    Perez Lopez, R.
    Garcia Hernandez, A. M.
    Cerezo Manchado, J. J.
    Blanquer Blanquer, M.
    Martinez Garcia, A. B.
    Melero Amor, A.
    Garcia Candel, F.
    Moraleda Jimenez, J. M.
    HAEMATOLOGICA, 2017, 102 : 97 - +
  • [36] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
    Plesner, Torben
    Arkenau, Hendrik-Tobias
    Lokhorst, Henk M.
    Gimsing, Peter
    Krejcik, Jakub
    Lemech, Charlotte
    Minnema, Monique C.
    Lassen, Ulrik
    Laubach, Jacob P.
    Ahmadi, Tahamtan
    Yeh, Howard
    Guckert, Mary E.
    Feng, Huaibao
    Brun, Nikolai Constantin
    Lisby, Steen
    Basse, Linda
    Palumbo, Antonio
    Richardson, Paul G.
    BLOOD, 2014, 124 (21)
  • [37] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
    Plesner, T.
    Arkenau, H. T.
    Lokhorst, H. M.
    Gimsing, P.
    Krejcik, J.
    Lemech, C.
    Minnema, M. C.
    Lassen, U.
    Ahmadi, T.
    Yeh, H.
    Guckert, M.
    Brun, N. C.
    Lisby, S.
    Basse, L.
    Palumbo, A.
    Richardson, P. G.
    HAEMATOLOGICA, 2014, 99 : 104 - 104
  • [38] A comparison of the efficacy and safety of ixazomib and lenalidomide combined with dexamethasone in the treatment of multiple myeloma
    Zheng, Zhipan
    Lin, Kai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 5248 - 5255
  • [39] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
    Chen, Christine
    Reece, Donna E.
    Siegel, David
    Niesvizky, Ruben
    Boccia, Ralph V.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Richardson, Paul
    Matous, Jeffrey
    Kumar, Shaji
    Bahlis, Nizar J.
    Alsina, Melissa
    Vescio, Robert
    Coutre, Steven E.
    Pietronigro, Dennis
    Knight, Robert D.
    Zeldis, Jerome B.
    Rajkumar, Vincent
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170
  • [40] Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone
    San-Miguel, Jesus F.
    Dimopoulos, Meletios A.
    Stadtmauer, Edward A.
    Rajkumar, S. Vincent
    Siegel, David
    Bravo, Marie-Laure
    Olesnyckyj, Marta
    Knight, Robert D.
    Zeldis, Jerome B.
    Harousseau, Jean-Luc
    Weber, Donna M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01): : 38 - 43
12345